Blue Trust’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
KCM
Blue Trust's XFOR Position: Q3 2026 in Review
Blue Trust held its X4 Pharmaceuticals (XFOR) position steady in Q3 2026 at 284 shares worth $824. The position accounts for ﹤0.01% of the portfolio, ranked #2201.
Blue Trust first reported a position in XFOR in Q2 2022 and has held it in 18 quarters since. The position peaked at $17K in Q3 2023. 59 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- Blue Trust held 284 shares of X4 Pharmaceuticals worth $824 as of Q3 2026.
- Blue Trust left its X4 Pharmaceuticals share count unchanged in Q3 2026.
- X4 Pharmaceuticals made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2201 holding.
- Blue Trust first reported a position in X4 Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's X4 Pharmaceuticals position peaked at $17K in Q3 2023.
- 59 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.